首页> 外国专利> METHOD OF IMPROVING THE CONTROL OF PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES OF ACTIVE INFUSION SUBSTANCE

METHOD OF IMPROVING THE CONTROL OF PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES OF ACTIVE INFUSION SUBSTANCE

机译:改善活性注入物质药动学和药理特性控制的方法

摘要

Non-porous solid microspheres have a dia. of 5-300 microns and consist of a mixt. of at least one injectable drug and a carrier. Provided the carrier is a substance naturally present in the recipient organism, it is stable in the solid state at temps. up to at least 60 deg. C and in the recipient physiological medium, and has dissolution kinetics in the recipient organism that are slower than the release kinetics of the drug in the same organism. Carrier is pref. coprosterol, glycocholic acid, cholesterol or a cholesterol este. Drug is pref. e.g, lorazepam, haloperidol, diazepam, biperiden, trihexyphenidyl.HCl, clonazepam, morphine, metoclopramide, acepromazine maleate, domperidone, vincamine etc. Microspheres are produced by dispersing the drug in the carrier, melting the mixt. in an inert gas atmos., spraying the melt under inert gas pressure, cooling the spray to solidify the droplets, and screening the resulting microspheres.
机译:无孔固体微球具有直径。 5-300微米,由混合料组成。至少一种可注射药物和载体。如果载体是受体生物体中天然存在的物质,则其在温度下在固态下是稳定的。至少达到60度C和受体生物介质中,并且在受体生物体中具有比在相同生物体中药物的释放动力学慢的溶解动力学。承运人是首选。异丙酚,糖胆酸,胆固醇或胆固醇este。毒品是首选。例如劳拉西m,氟哌啶醇,地西epa,双哌啶,三己基哌啶·HCl,氯硝西am,吗啡,甲氧氯普胺,马来酸醋丙嗪,多潘立酮,长春胺等。微球是通过将药物分散在载体中,融化混合物而制得的。在惰性气体气氛中,在惰性气体压力下喷雾熔体,冷却喷雾以固化液滴,并筛选所得的微球。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号